Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

SecurityKRYS / Krystal Biotech, Inc.
InstitutionVerition Fund Management LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Verition Fund Management LLC closes position in KRYS / Krystal Biotech, Inc.

On May 15, 2026 - Verition Fund Management LLC filed a 13F-HR form disclosing ownership of 0 shares of Krystal Biotech, Inc. (US:KRYS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 16,969 shares of Krystal Biotech, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 0 -100.00 0
2026-02-13 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 16,969 -14,364 -45.84 4,184 -24.37 0.0164
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 31,333 4,819 18.18 5,531 51.78 0.0228
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 26,514 7,889 42.36 3,645 8.52 0.0162
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 18,625 -6,277 -25.21 3,358 -13.92 0.0156
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 24,902 8,902 55.64 3,901 33.96 0.0154
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 16,000 -1,989 -11.06 2,912 -11.84 0.0147
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 17,989 -43,811 -70.89 3,304 -69.96 0.0181
2024-05-14 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 61,800 -34,158 -35.60 10,996 -7.63 0.0752
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 95,958 -31,112 -24.48 11,905 -19.24 0.0932
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 127,070 35,338 38.52 14,740 36.87 0.1720
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 91,732 -1,912 -2.04 10,769 43.64 0.1437
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 93,644 13,083 16.24 7,497 17.47 0.1037
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 80,561 12,909 19.08 6,382 35.36 0.0997
2023-01-18 2022-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 67,652 12,908 23.58 4,715 31.19 0.0528
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 67,652 12,908 4,715 0.0534
2022-08-30 2022-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 54,744 23,578 75.65 3,594 73.29 0.0711
2022-08-15 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 54,744 23,578 3,594 0.0608
2022-06-02 2022-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 31,166 -44,948 -59.05 2,074 -61.04 0.0249
2022-05-13 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 31,166 -44,948 2,074 0.0238
2022-05-03 2021-12-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 76,114 10,069 15.25 5,324 54.41 0.0364
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 76,114 10,069 5,324 0.0345
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 66,045 47,464 255.44 3,448 172.78 0.0299
2021-08-16 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 18,581 -51,266 -73.40 1,264 -76.51 0.0115
2021-05-18 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 69,847 -7,697 -9.93 5,381 15.65 0.0607
2021-02-16 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 77,544 21,515 38.40 4,653 92.91 0.0409
2020-11-16 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 56,029 -10,457 -15.73 2,412 -12.42 0.0482
2020-08-14 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 66,486 -19,504 -22.68 2,754 -25.93 0.0906
2020-05-15 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 85,990 61,798 255.45 3,718 177.46 0.1468
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 24,192 -45,002 -65.04 1,340 -44.24 0.0244
2019-11-14 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 69,194 6,544 10.45 2,403 -4.76 0.0662
2019-08-14 2019-06-30 13F KRYSTAL BIOTECH COM 501147102 62,650 62,650 2,523 0.0710
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.